Table 1.
Sporadic | BRCA1 | P value | BRCA2 | P value | |
---|---|---|---|---|---|
DDX3 expression [n (%)] | 0.337a | 0.624a | |||
Absent | 3 (1) | 0 | 0 | ||
Weak | 34 (13) | 19 (18) | 5 (17) | ||
Moderate | 148 (56) | 59 (57) | 18 (62) | ||
Strong | 80 (30) | 25 (24) | 6 (21) | ||
Age [median (IQR)] | 58 (18) | 40 (11.5) | <0.001b | 50 (11) | <0.001b |
B&R grade [n (%)] | <0.001 | 0.014a | |||
1 | 45 (17) | 2 (2) | 0 | ||
2 | 99 (37) | 15 (16) | 8 (31) | ||
3 | 121 (46) | 78 (82) | 18 (69) | ||
Missing | 0 | 0 | 1 | ||
MAI [median (IQR)] | 12 (18) | 25 (25) | <0.001b | 17 (13) | 0.110a |
Missing | 0 | 13 | 3 | ||
Histological type [n (%)] | 0.064 | 0.667a | |||
Invasive ductal carcinoma | 225 (85) | 80 (84) | 25 (93) | ||
Invasive lobular carcinoma | 24 (9) | 4 (4) | 2 (7) | ||
Other | 15 (6) | 11 (12) | 0 | ||
Missing | 1 | 8 | 2 | ||
Tumor size (cm) [median (IQR)] | 2 (2) | 2 (2) | 0.924b | 1 (1) | 0.029b |
Missing | 22 | 26 | 6 | ||
ER [n (%)] | <0.001 | 1 | |||
Negative | 50 (19) | 76 (77) | 5 (19) | ||
Positive | 215 (81) | 23 (23) | 22 (81) | ||
Missing | 0 | 4 | 2 | ||
PR [n (%)] | <0.001 | 0.171 | |||
Negative | 87 (33) | 81 (83) | 13 (48) | ||
Positive | 177 (67) | 17 (17) | 14 (52) | ||
Missing | 1 | 5 | 2 | ||
HER2 [n (%)] | 0.828 | 1a | |||
Negative | 243 (92) | 94 (93) | 26 (93) | ||
Positive | 22 (8) | 7 (7) | 2 (7) | ||
Missing | 0 | 2 | 1 | ||
Molecular classification [n (%)] | <0.001a | 0.897a | |||
Luminal A | 208 (78) | 20 (21) | 21 (81) | ||
Luminal B | 12 (5) | 4 (4) | 1 (4) | ||
HER2 overexpressing | 10 (4) | 4 (4) | 0 | ||
Basal-like | 35 (13) | 67 (71) | 4 (15) | ||
Unclassified | 0 | 0 | 0 | ||
Missing |
P value calculated by Chi-square test unless otherwise indicated
n number, B&R Bloom and Richardson, MAI mitotic activity index, IQR interquartile range
Fisher exact test
Mann–Whitney U test